Please use this identifier to cite or link to this item: https://www.arca.fiocruz.br/handle/icict/31735
Full metadata record
DC FieldValue
dc.contributor.authorFolegatti, Pedro M.
dc.contributor.authorSiqueira, André M.
dc.contributor.authorMonteiro, Wuelton M.
dc.contributor.authorLacerda, Marcus Vinícius G.
dc.contributor.authorDrakeley, Chris J.
dc.contributor.authorBraga, Érika M.
dc.date.accessioned2019-02-19T11:51:05Z
dc.date.available2019-02-19T11:51:05Z
dc.date.issued2017
dc.identifier.citationFOLEGATTI, Pedro M. et al. A systematic review on malaria sero-epidemiology studies in the Brazilian Amazon: insights into immunological markers for exposure and protection. Malaria Journal, v. 16, n. 107, p. 1-15, 2017.
dc.identifier.issn1475-2875
dc.identifier.urihttps://www.arca.fiocruz.br/handle/icict/31735
dc.language.isoeng
dc.publisherBMC
dc.rightsopen access
dc.titleA systematic review on malaria sero-epidemiology studies in the Brazilian Amazon: insights into immunological markers for exposure and protection
dc.typeArticle
dc.identifier.doi10.1186/s12936-017-1762-7
dc.description.abstractenBackground: Considerable success in reducing malaria incidence and mortality has been achieved in Brazil, leading to discussions over the possibility of moving towards elimination. However, more than reporting and counting clinical cases, elimination will require the use of efficient tools and strategies for measuring transmission dynamics and detecting the infectious reservoir as the primary indicators of interest for surveillance and evaluation. Because acquisition and maintenance of anti-malarial antibodies depend on parasite exposure, seroprevalence rates could be used as a reliable tool for assessing malaria endemicity and an adjunct measure for monitoring transmission in a rapid and cost-effective manner. Methods: This systematic review synthesizes the existing literature on seroprevalence of malaria in the Brazilian Amazon Basin. Different study designs (cross-sectional surveys and longitudinal studies) with reported serological results in well-defined Brazilian populations were considered. Medline (via PubMed), EMBASE and LILACS databases were screened and the articles were included per established selection criteria. Data extraction was performed by two authors and a modified critical appraisal tool was applied to assess the quality and completeness of cross-sectional studies regarding defined variables of interest. Results: From 220 single records identified, 23 studies were included in this systematic review for the qualitative synthesis. Five studies reported serology results on Plasmodium falciparum, 14 papers assessed Plasmodium vivax and four articles reported results on both Plasmodium species. Considerable heterogeneity among the evaluated malarial antigens, including sporozoite and blood stage antigens, was observed. The majority of recent studies analysed IgG responses against P. vivax antigens reflecting the species distribution pattern in Brazil over the last decades. Most of the published papers were cross-sectional surveys (73.9%) and only six cohort studies were included in this review. Three studies pointed to an association between antibodies against circumsporozoite protein of both P. falciparum and P. vivax and malaria exposure. Furthermore, five out 13 cross-sectional studies evidenced a positive association between IgG antibodies to the conserved 19-kDa C-terminal region of the merozoite surface protein 1 of P. vivax (PvMSP119) and malaria exposure. Conclusions: This systematic review identifies potential biomarkers of P. falciparum and P. vivax exposure in areas with variable and unstable malaria transmission in Brazil. However, this study highlights the need for standardization of further studies to provide an ideal monitoring tool to evaluate trends in malaria transmission and the effectiveness of malaria intervention programmes in Brazil. Moreover, the score-based weighted tool developed and used in this study still requires further validation.
dc.creator.affilliationLondon School of Hygiene & Tropical Medicine. Department of Immunology and Infection. London, UK.
dc.creator.affilliationFundação Oswaldo Cruz. Instituto Nacional de Infectologia Evandro Chagas., Rio de Janeiro, RJ, Brasil.
dc.creator.affilliationFundação de Medicina Tropical Dr. Heitor Vieira Dourado. Manaus, AM, Brasil / Universidade do Estado do Amazonas. Escola Superior de Ciências da Saúde. Manaus, AM, Brasil.
dc.creator.affilliationFundação de Medicina Tropical Dr. Heitor Vieira Dourado. Manaus, AM, Brasil / Fundação Oswaldo Cruz. Instituto de Pesquisas Leônidas e Maria Deane. Manaus, AM, Brasil
dc.creator.affilliationLondon School of Hygiene & Tropical Medicine. Department of Immunology and Infection. London, UK
dc.creator.affilliationLondon School of Hygiene & Tropical Medicine. Department of Immunology and Infection. London, UK / Universidade Federal de Minas Gerais. Departamento de Parasitologia. Belo Horizonte, MG, Brasil.
dc.subject.enPlasmodium falciparum
dc.subject.enPlasmodium vivax
dc.subject.enAntibodies
dc.subject.enBrazil
dc.subject.enSero-epidemiology
dc.subject.enSystematic review
dc.identifier.eissn1475-2875
Appears in Collections:AM - ILMD - Artigos de Periódicos
INI - Artigos de Periódicos

Files in This Item:
File Description SizeFormat 
ve_Folegatti_Pedro_etal_INI_2017.pdf1.1 MBAdobe PDFView/Open


FacebookTwitterDeliciousLinkedInGoogle BookmarksBibTex Format mendeley Endnote DiggMySpace

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.